FDA approves
nausea drug for cancer patients

The Food and Drug Administration on Wednesday approved Merck's antinausea medication Emend for use in conjunction with other antinausea drugs to treat cancer patients receiving chemotherapy. Emend, made by Merck, was shown in a study of breast cancer patients to significantly reduce the chances for nausea and vomiting when added to a regimen of already-approved antinausea drugs. Many of the women studied reported a complete lack of nausea when taking regimens including Emend. (Advocate.com)